![Cynthia L. Grosskreutz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cynthia L. Grosskreutz
Directeur/Bestuurslid bij ONL Therapeutics, Inc.
Profiel
Cynthia L.
Grosskreutz has a current job as a Director at ONL Therapeutics, Inc.
Actieve functies van Cynthia L. Grosskreutz
Bedrijven | Functie | Begin |
---|---|---|
ONL Therapeutics, Inc.
![]() ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
ONL Therapeutics, Inc.
![]() ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI. | Health Technology |